New Leukemia Drug in Early Clinical Testing Offers Some Clues for Better Treatment

While testing a new drug designed to treat chronic leukemia, researchers at Cleveland Clinic discovered new markers that could identify which patients would receive maximum benefit from the treatment.
News Medical